XENON PHARMACEUTICALS INC (XENE) Institutional Ownership and Insiders Activity
XENON PHARMACEUTICALS INC (XENE) is widely held by institutional investors, with 305 firms reporting positions valued at approximately $5.98B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Fmr Llc is the largest disclosed holder, reporting approximately $582.35M in XENE holdings in its latest filing.
Recent insider activity includes 7 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
305
Total Reported Value
$5.98B
Largest Holder
Fmr Llc
Largest Position
$582.35M
Insider Transactions (90d)
7
Latest Filing Quarter
Q2 2026
New Institutional Positions
50
Funds Exiting Positions
31
Top Institutional Owners
View allInvestorReported Balance
- Fmr Llc$582.35M
- Blackrock, Inc.$454.06M
- Avoro Capital Advisors Llc$348.75M
- Polar Capital Holdings Plc$275.88M
- Driehaus Capital Management Llc$266.70M
XENE News
All news- Driehaus Capital Management Q2 Portfolio Shifts Focus on Technology & Healthcare
Aug 17, 2026 · valut.ai
Related XENE Institutional Insights:
- XENE 13F Institutional Holders
- XENE Superinvestors
- XENE Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- XENE Insider Trading & SEC Form 4 Activity
- XENE Articles
- Top Institutional Investor Stock Rankings